The Trump administration’s sweeping overhaul of government spending has come to the U.S. Department of Health and Human Services, with employees receiving notices on Tuesday that their jobs have been eliminated.
AI will help determine who is achieving their health potential and who is not, helping to fulfill the HIMSS vision for every human everywhere to realize their full health potential, says Anne Snowdon, HIMSS’ chief scientific research officer.
CVS Health’s pharmacy benefit manager, Caremark, is bringing Omada Health on board to be a part of its weight management program, with a focus on access to GLP-1 drugs.
A hearing before a House Energy and Commerce subcommittee Tuesday on the safety of legacy medical devices became a forum for Democrats to protest staffing cuts at Health and Human Services, one of the federal departments tasked with cybersecurity protection.
Jong-Soo Choi, CTO at South Korea’s Samsung Medical Center and 2025 HIMSS Changemaker Awardee, says his health system achieved the HIMSS maturity model goal by focusing on improving care quality and patient engagement, even while dealing with challenges such as the cloud and data.
Ambient listening allows for a natural conversation with a patient and puts the right information into the medical record and without the burden of chart documentation, says Changemaker Mary Joy Garcia-Dia, program director of nursing informatics at NewYork-Presbyterian Hospital.
Cleveland Clinic and G42, an artificial intelligence-focused technology group headquartered in Abu Dhabi, United Arab Emirates (UAE), are teaming up to drive AI-powered advancements in healthcare, both in the U.S. and globally. As part of this initiative, the organizations will form a joint task force to evaluate and accelerate potential projects and collaborative opportunities aimed […]
Lawmakers in the House of Representatives have rolled out a bipartisan bill that would task board-certified specialists with determining the medical need of prior authorization requests.
Cigna subsidiary Evernorth Health Services is expanding its coverage of NeuroStar Transcranial Magnetic Stimulation (TMS) to include adolescents aged 15 and older living with major depressive disorder, in
Dr. Peter Marks has resigned his position as director of the Center for Biologics Evaluation and Research at the Food and Drug Administration.